Martin Shkreli's former company files for bankruptcy

KaloBios Pharmaceuticals Inc., which earlier this month fired CEO Martin Shkreli, has filed for Chapter 11 bankruptcy.

In the Tuesday filing, the company listed both its assets and liabilities in the range of $1 million to $10 million.

KaloBios named Shkreli as its CEO on Nov. 20, after Shkreli and a consortium of investors bought about 70 percent of its shares. He was fired after being arrested for alleged securities fraud.

Read more from Reuters.